StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Wolfe Research Starts Moderna (MRNA) at Outperform
November 8, 2021 5:53 PM
Wolfe Research analyst Andrew Galler initiates coverage on Moderna (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
New Coverage
Next Articles
Moderna (MRNA) Requests to Expand Conditional Marketing Authorization for its COVID-19 Vaccine in the EU to Include Children Ages 6-11 Years
November 9, 2021 8:33 AM
